{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T20:08:04Z","timestamp":1706299684277},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,5]]},"DOI":"10.1007\/bf01741094","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T15:48:34Z","timestamp":1118677714000},"page":"210-213","source":"Crossref","is-referenced-by-count":10,"title":["Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"L. Th.","family":"Vlasveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"van de Wiel-van Kemenade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Sein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P. W.","family":"Gallee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. T.","family":"Krediet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J. M.","family":"Mellief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. M.","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"Figdor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01741094_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM198401053100107","volume":"310","author":"SD Averbuch","year":"1984","unstructured":"Averbuch SD, Austin III HA, Sherwin SA, Antonovych T, Bunn PA, Longo DL (1984) Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte A interferon therapy for mycosis fungoides. N Engl J Med 310: 32","journal-title":"N Engl J Med"},{"key":"BF01741094_CR2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/0277-5379(90)90208-B","volume":"26","author":"S Bastuji-Garin","year":"1990","unstructured":"Bastuji-Garin S, Chosidow O, Lang P, Roujeau J-C, Revuz J (1990) Transient proteinuria during interleukin-2 therapy. Eur J Cancer 26: 924","journal-title":"Eur J Cancer"},{"key":"BF01741094_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00704253","volume":"404","author":"H Beaufils","year":"1984","unstructured":"Beaufils H, Patte R, Aubert Ph, Camey M, Kuss R, Barbagelatta M, Chomette G (1984) Renal Immunopathology in renal cell carcinoma. Virchows Arch [A] 404: 87","journal-title":"Virchows Arch [A]"},{"key":"BF01741094_CR4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-106-6-817","volume":"106","author":"A Belldegrun","year":"1987","unstructured":"Belldegrun A, Webb DE, Austin III HA, Steinberg SM, White DE, Linehan WM, Rosenberg SA (1987) Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer. Ann Intern Med 106: 817","journal-title":"Ann Intern Med"},{"key":"BF01741094_CR5","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1073\/pnas.87.18.6949","volume":"87","author":"JR Bender","year":"1990","unstructured":"Bender JR, Pardi R, Engleman E (1990) T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells. Proc Natl Acad Sci USA 87: 6949","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01741094_CR6","doi-asserted-by":"crossref","unstructured":"Bolhuis RLH, Stoter G, Eggermont AMM. Characteristics and uses of IL-2 in immunotherapy. Biotherapy 1989: 1\u2013153","DOI":"10.1007\/BF02170884"},{"key":"BF01741094_CR7","first-page":"97","volume":"250","author":"JS Cameron","year":"1988","unstructured":"Cameron JS (1988) Allergic interstitial nephritis: clinical features and pathogenesis. Q J Med 250: 97","journal-title":"Q J Med"},{"key":"BF01741094_CR8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000186722","volume":"60","author":"MJM Diekman","year":"1992","unstructured":"Diekman MJM, Vlasveld LT, Krediet RT, Rankin EM, Arisz L (1992) Acute interstitial nephritis during continuous intravenous administration of low-dose interleukin-2. Nephron 60: 122","journal-title":"Nephron"},{"key":"BF01741094_CR9","first-page":"469","volume-title":"Immunodiagnosis of cancer","author":"T Ebert","year":"1990","unstructured":"Ebert T, Bander NH (1990) Immunodiagnosis of renal cell carcinoma. In: Herberman RB, Mercer DW (eds) Immunodiagnosis of cancer. Dekker, New York, p 469"},{"key":"BF01741094_CR10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000168365","volume":"11","author":"DA Feinfeld","year":"1991","unstructured":"Feinfeld DA, D'Agati V, Dutcher JP, Werfel SB, Lynn RI, Wiernik PH (1991) Interstitial nephritis in a patient receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells. Am J Nephrol 11: 489","journal-title":"Am J Nephrol"},{"key":"BF01741094_CR11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0002-9343(81)90241-2","volume":"71","author":"MF Fer","year":"1981","unstructured":"Fer MF, McKinney TD, Richardson RL, Hande KR, Oldham RK, Greco FA (1981) Cancer and the kidney: renal complication of neoplasms. Am J Med 71: 704","journal-title":"Am J Med"},{"key":"BF01741094_CR12","first-page":"1965","volume":"48","author":"JA Hank","year":"1988","unstructured":"Hank JA, Kohler PC, Weil-Hillman G, Rosenthal N, Moore KH, Storer B, Minkoff D, Bradshaw J, Bechhofer R, Sondel PM (1988) In vivo induction of the lymphokine-activated killer phenomenon: interleukin-2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin-2. Cancer Res 48: 1965","journal-title":"Cancer Res"},{"key":"BF01741094_CR13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4049\/jimmunol.136.2.526","volume":"136","author":"CJ Kelly","year":"1986","unstructured":"Kelly CJ, Korngold R, Mann R, Clayman M, Haverty T, Neilson EG, (1986) Spontaneous interstitial nephritis in kdkd mice: II. Characteriziation of a tubular antigen-specific, H-2K-restricted Lyt-2+ effector T cell that mediates destructive tubulointerstitial injury. J Immunol 136: 526","journal-title":"J Immunol"},{"key":"BF01741094_CR14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0002-9343(78)90529-6","volume":"64","author":"HO Kerpen","year":"1978","unstructured":"Kerpen HO, Bhat JG, Feiner HD, Baldwin DS (1978) Membranous nephropathy associated with renal cell carcinoma: evidence against a role of renal tubular or tumor antibodies in pathogenesis. Am J Med 64: 863","journal-title":"Am J Med"},{"key":"BF01741094_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002371-199110000-00006","volume":"10","author":"AS Koo","year":"1991","unstructured":"Koo AS, Tso C-L, Shimabukuro T, Peyret C, deKernion JB, Belldegrun A (1991) Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma. J Immunother 10: 347","journal-title":"J Immunother"},{"key":"BF01741094_CR16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0046-8177(90)90005-P","volume":"21","author":"AH Kragel","year":"1990","unstructured":"Kragel AH, Travis WD, Feinberg L, Pittaluga S, Striker LM, Roberts WC, Lotze MT, Yang JJ, Rosenberg SA (1990) Pathological findings associated with interleukin-2 based immunotherapy for cancer: a postmortem study of 19 patients. Hum Pathol 21: 493","journal-title":"Hum Pathol"},{"key":"BF01741094_CR17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0065-2776(08)60825-1","volume":"50","author":"G Kroemer","year":"1991","unstructured":"Kroemer G, Andreu JL, Gonzalo JA, Gutierrez-Ramos JC, Martinez-AC (1991) Interleukin-2, autotolerance, and autoimmunity. Adv Immunol 50: 147","journal-title":"Adv Immunol"},{"key":"BF01741094_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1097-0142(19800201)45:3<495::AID-CNCR2820450313>3.0.CO;2-2","volume":"45","author":"An Krutchik","year":"1980","unstructured":"Krutchik An, Buzdar AU, Akhtar M, Blumenschein GR (1980) Immune-complex glomerulonephritis secondary to nonspecific immunotherapy. Cancer 45: 495","journal-title":"Cancer"},{"key":"BF01741094_CR19","first-page":"729","volume":"63","author":"AMM Miltenburg","year":"1988","unstructured":"Miltenburg AMM, Meijer-Paape ME, Daha MR, Paul LC (1988) Lymphokine-activated killer cells lyse human renal cancer lines and cultured normal kidney cells. Immunology 63: 729","journal-title":"Immunology"},{"key":"BF01741094_CR20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/ki.1989.118","volume":"35","author":"EG Neilson","year":"1989","unstructured":"Neilson EG (1989) Pathogenesis and therapy of interstitial nephritis. Kidney Int 35: 1257","journal-title":"Kidney Int"},{"key":"BF01741094_CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01741708","volume":"32","author":"EWP Nijhuis","year":"1990","unstructured":"Nijhuis EWP, v\/d Wiel-van Kemenade E, Figdor CG, van Lier RAW (1990) Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies. Cancer Immunol Immunother 32: 245","journal-title":"Cancer Immunol Immunother"},{"key":"BF01741094_CR22","first-page":"301","volume":"123","author":"E Oosterwijk","year":"1986","unstructured":"Oosterwijk E, Ruiter DJ, Wakka JC, Huiskens-v d Mey JW, Jonas U, Fleuren GJ, Zwartendijk J, Hoedemaeker Ph, Warnaar SO (1986) Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol 123: 301","journal-title":"Am J Pathol"},{"key":"BF01741094_CR23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.2910380406","volume":"38","author":"E Oosterwijk","year":"1986","unstructured":"Oosterwijk E, Ruiter DJ, Hoedemaeker PhJ, Pauwels EKJ, Jonas U, Zwartendijk J, Warnaar SO (1986) Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 38: 489","journal-title":"Int J Cancer"},{"key":"BF01741094_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-1759(88)90238-4","volume":"109","author":"K Oshimi","year":"1988","unstructured":"Oshimi K, Oshimi Y, Saito H, Mizoguchi H (1988) Cytotoxicity of interleukin-2-activated lymphocytes for autologous normal blood mononuclear cells. J Immunol Methods 109: 161","journal-title":"J Immunol Methods"},{"key":"BF01741094_CR25","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1200\/JCO.1990.8.11.1839","volume":"8","author":"CL Shalmi","year":"1990","unstructured":"Shalmi CL, Dutcher JP, Feinfeld DA, Chun KJ, Saleemi K, Freeman LM, Lynn RI, Wiernik PH (1990) Acute renal dysfunction during interleukin-2 treatment: suggestion of an intrinsic renal lesion. J Clin Oncol 8: 1839","journal-title":"J Clin Oncol"},{"key":"BF01741094_CR26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0002-9343(87)90941-7","volume":"83","author":"SC Textor","year":"1987","unstructured":"Textor SC, Margolin K, Blayney D, Carlson J, Doroshow J (1987) Renal, volume, and hormonal changes during therapeutic administration of recombinant interleukin-2 in man. Am J Med 83: 1055","journal-title":"Am J Med"},{"key":"BF01741094_CR27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/bjc.1992.157","volume":"65","author":"LT Vlasveld","year":"1992","unstructured":"Vlasveld LT, Rankin EM, Hekman A, Rodenhuis S, Beijnen JH, Hilton AM, Dubbelman AC, Vyth-Dreese FA, Melief CJM (1992) A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer: part I. Clinical aspects. Br J Cancer 65: 744","journal-title":"Br J Cancer"},{"key":"BF01741094_CR28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0002-9343(87)90936-3","volume":"83","author":"J Wang","year":"1987","unstructured":"Wang J, Walle A, Gordon B, Novogrodsky A, Suthanthiran M, Rubin AL, Morrison H, Silver RT, Stenzel KH (1987) Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2. Am J Med 83: 1016","journal-title":"Am J Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01741094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01741094\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01741094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T19:11:46Z","timestamp":1706296306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01741094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["BF01741094"],"URL":"https:\/\/doi.org\/10.1007\/bf01741094","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}